RIZAPORT(R) (RHB-103) - acute migraines (approved for marketing in Germany) In 2016, RedHill and its co-development partner, IntelGenx Corp. (TSXV: IGX; OTCQX: IGXT), entered into exclusive license agreements for the …
IntelGenx Corp. (IGX.V)(IGXT.OB) has initiated a phase 1 clinical trial of Montelukast ... NVCR closed Wednesday's trading at $11.96, down 1.97%. In after hours, the stock was up 5.69% to $12.64. An FDA panel, which reviewed the …
SAINT-LAURENT, QUEBEC -- (Marketwired) -- 11/09/17 -- IntelGenx Corp. (TSX VENTURE: IGX)(OTCQX: IGXT) (the "Company" or "IntelGenx"), today announced that it has submitted a clinical trial application ("CTA") to Health Canada …
Whether by whim or design, President Donald Trump keeps adding fuel to his incendiary Twitter battle against the media. The press is an easy target for the Republican president, and one his supporters love to hate. But the escalating …
Redhill Biopharma Ltd : RedHill Biopharma and IntelGenx announce definitive agreement for commercialization of RIZAPORT™ for migraines with Grupo Juste in Spain and additional potential territories . Commercial launch in Spain is …
adding that “excitement leading into the Model 3 reveal and the recent recovery in gas prices have boosted investor sentiment around the stock.” Related Link: The Tesla Model 3 Launch: Elon Musk's Moment Of Truth? The analyst …
A Prescription Drug User Fee Act (PDUFA) date is expected to be set by the FDA for the first half of 2018, if the …
NEW YORK, Jan. 30, 2017 /CNW/ -- PR Newswire and BetterInvesting (NAIC) today announced the agenda for the …
The trading setup for CHMA looks very enticing. google awe-som*sto-cks - they offer pretty good trade alerrts. you dont have to trade their tickers but it definetly helps you recognize possible patterns for stocks you're trading. Overall I think …